GNMSF vs AMZN: Which Stock is Better?

Side-by-side comparison of Genmab A/S and Amazon Com Inc in 2026

Comparison Updated:

GNMSF

Genmab A/S

$330.37

AMZN

Amazon Com Inc

$231.00

Key Metrics Comparison

MetricGNMSFAMZNWinner
Market Cap$20.35B$2.56TAMZN
P/E Ratio14.4733.77GNMSF
EPS (TTM)$22.83$7.08GNMSF
Revenue Growth0.2%0.1%GNMSF
Gross Margin94.4%50.0%GNMSF

Analyze GNMSF

Full quant analysis

Analyze AMZN

Full quant analysis

Analyze Each Stock

Frequently Asked Questions

Is GNMSF or AMZN a better investment?

Comparing GNMSF and AMZN: Genmab A/S has a market cap of $20.35B while Amazon Com Inc has $2.56T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.

What is the difference between GNMSF and AMZN?

GNMSF (Genmab A/S) and AMZN (Amazon Com Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.

Which stock has better value: GNMSF or AMZN?

Based on P/E ratios, GNMSF trades at a lower multiple (14.5x vs 33.8x).

Which is growing faster: GNMSF or AMZN?

GNMSF has higher revenue growth at 0.2% vs 0.1% for AMZN.

Which company is more profitable: GNMSF or AMZN?

Genmab A/S (GNMSF) has higher gross margins at 94.4% compared to 50.0% for AMZN.

Which is the larger company: GNMSF or AMZN?

Amazon Com Inc (AMZN) is larger with a market cap of $2.56T compared to $20.35B for GNMSF.

Should I buy GNMSF or AMZN in 2026?

Both GNMSF and AMZN have investment merit. GNMSF trades at $330.37 while AMZN trades at $231.00. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.

What are the key differences between GNMSF and AMZN stock?

Key differences: Market Cap ($20.35B vs $2.56T), P/E Ratio (14.5x vs 33.8x), Revenue Growth (0.2% vs 0.1%), Gross Margin (94.4% vs 50.0%).

Popular Stock Comparisons